Search details
1.
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus.
Nature
; 527(7578): 323-8, 2015 Nov 19.
Article
in English
| MEDLINE | ID: mdl-26536114
2.
Potent and selective inhibitors of receptor-interacting protein kinase 1 that lack an aromatic back pocket group.
Bioorg Med Chem Lett
; 29(12): 1497-1501, 2019 06 15.
Article
in English
| MEDLINE | ID: mdl-31000154
3.
Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability.
J Biol Chem
; 288(37): 26926-43, 2013 Sep 13.
Article
in English
| MEDLINE | ID: mdl-23897821
4.
HPK1 citron homology domain regulates phosphorylation of SLP76 and modulates kinase domain interaction dynamics.
Nat Commun
; 15(1): 3725, 2024 May 02.
Article
in English
| MEDLINE | ID: mdl-38697971
5.
Novel triazolo-pyrrolopyridines as inhibitors of Janus kinase 1.
Bioorg Med Chem Lett
; 23(12): 3592-8, 2013 Jun 15.
Article
in English
| MEDLINE | ID: mdl-23642482
6.
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance.
Nat Cancer
; 4(6): 812-828, 2023 06.
Article
in English
| MEDLINE | ID: mdl-37277530
7.
pH-Sensitive, N-ethoxybenzylimidazole (NEBI) bifunctional crosslinkers enable triggered release of therapeutics from drug delivery carriers.
Org Biomol Chem
; 8(22): 5105-9, 2010 Nov 21.
Article
in English
| MEDLINE | ID: mdl-20820656
8.
Small Molecule Dysregulation of TEAD Lipidation Induces a Dominant-Negative Inhibition of Hippo Pathway Signaling.
Cell Rep
; 31(12): 107809, 2020 06 23.
Article
in English
| MEDLINE | ID: mdl-32579935
9.
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases.
Cell Death Differ
; 27(1): 161-175, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31101885
10.
Structural investigation of human S. aureus-targeting antibodies that bind wall teichoic acid.
MAbs
; 10(7): 979-991, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30102105
11.
Corrigendum: A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action.
Nat Commun
; 8: 15779, 2017 05 25.
Article
in English
| MEDLINE | ID: mdl-28541305
12.
A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action.
Nat Commun
; 8: 14234, 2017 01 19.
Article
in English
| MEDLINE | ID: mdl-28102191
13.
Discovery of (R,E)-N-(7-Chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1H-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a Novel, Potent, and WT Sparing Covalent Inhibitor of Oncogenic (L858R, ex19del) and Resistant (T790M) EGFR Mutants for the Treatment of EGFR Mutant Non-Small-Cell Lung Cancers.
J Med Chem
; 59(14): 6671-89, 2016 07 28.
Article
in English
| MEDLINE | ID: mdl-27433829
14.
An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies.
Cell Host Microbe
; 14(1): 93-103, 2013 Jul 17.
Article
in English
| MEDLINE | ID: mdl-23870317
Results
1 -
14
de 14
1
Next >
>>